A Pisacane - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A Pisacane

Showing results (41-50 of 46) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 46 results.

British Journal of Cancer|November 11, 2017

Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patientsD Zugna, R Senetta, S Osella-Abate, et al.

Scientific Reports|April 17, 2020

Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancerS Capellero, J Erriquez, C Melano, et al.

European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2019

Predicting locally advanced rectal cancer response to neoadjuvant therapy with <sup>18</sup>F-FDG PET and MRI radiomics featuresV Giannini, S Mazzetti, I Bertotto, et al.

The British Journal of Dermatology|July 9, 2021

GJB5 association with BRAF mutation and survival in cutaneous malignant melanomaM Scatolini, A Patel, E Grosso, et al.

Oncoimmunology|May 4, 2018

CD44v6 as innovative sarcoma target for CAR-redirected CIK cellsV Leuci, G M Casucci, G Grignani, et al.

ESMO Open|May 13, 2021

High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patientsE Berrino, A Balsamo, A Pisacane, et al.

Pageof 5

Search research articles

Showing results (41-50 of 46) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 46 results.

British Journal of Cancer|November 11, 2017

Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patientsD Zugna, R Senetta, S Osella-Abate, et al.

Scientific Reports|April 17, 2020

Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancerS Capellero, J Erriquez, C Melano, et al.

European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2019

Predicting locally advanced rectal cancer response to neoadjuvant therapy with <sup>18</sup>F-FDG PET and MRI radiomics featuresV Giannini, S Mazzetti, I Bertotto, et al.

The British Journal of Dermatology|July 9, 2021

GJB5 association with BRAF mutation and survival in cutaneous malignant melanomaM Scatolini, A Patel, E Grosso, et al.

Oncoimmunology|May 4, 2018

CD44v6 as innovative sarcoma target for CAR-redirected CIK cellsV Leuci, G M Casucci, G Grignani, et al.

ESMO Open|May 13, 2021

High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patientsE Berrino, A Balsamo, A Pisacane, et al.

Pageof 5